{"log_id": 4512673784743353819, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.000179, "average": 0.98601, "min": 0.958487}, "location": {"width": 157, "top": 372, "height": 50, "left": 370}, "words": "【药物过量】"}, {"probability": {"variance": 0.016701, "average": 0.941194, "min": 0.569746}, "location": {"width": 843, "top": 418, "height": 86, "left": 422}, "words": "第一次出现溃疡或出血,腹泻或运血功能显著抑制时应停用甲氨蝶呤"}, {"probability": {"variance": 0.006557, "average": 0.971431, "min": 0.600837}, "location": {"width": 903, "top": 454, "height": 93, "left": 420}, "words": "在口服过量之后常见的症状包括药理学剂量水平出现的症状和体征,显著"}, {"probability": {"variance": 0.01339, "average": 0.965427, "min": 0.355668}, "location": {"width": 973, "top": 491, "height": 93, "left": 356}, "words": "的是血液系统和胃肠道的反应,例如白细胞减少、血小板减少、贫血、全细胞"}, {"probability": {"variance": 0.016962, "average": 0.93313, "min": 0.437273}, "location": {"width": 953, "top": 528, "height": 96, "left": 354}, "words": "减少、骨髓抑制、粘膜炎、口腔溃疡、恶心、呕吐、胃肠道溃疡和胃肠出血"}, {"probability": {"variance": 0.018006, "average": 0.954397, "min": 0.360028}, "location": {"width": 976, "top": 564, "height": 100, "left": 349}, "words": "曾报道在一些病例中没有出现症状。有药物过量致死的报道。在这些侧不"}, {"probability": {"variance": 0.012597, "average": 0.944324, "min": 0.639274}, "location": {"width": 834, "top": 603, "height": 91, "left": 349}, "words": "良事件如败血症或败血症性休克、肾功能衰竭和再生障碍性贫血也曾"}, {"probability": {"variance": 0.015939, "average": 0.944966, "min": 0.44801}, "location": {"width": 955, "top": 642, "height": 98, "left": 347}, "words": "命的毒性症状有厌食,进行性体重减轻,血性腹泻、白细胞减少,排每料迷"}, {"probability": {"variance": 0, "average": 0.99938, "min": 0.99938}, "location": {"width": 36, "top": 665, "height": 34, "left": 1287}, "words": "致"}, {"probability": {"variance": 0.013304, "average": 0.96005, "min": 0.396203}, "location": {"width": 891, "top": 683, "height": 96, "left": 411}, "words": "一旦发现甲氨蝶呤不慎过量,要尽快给与亚叶酸钙(亚叶酸),"}, {"probability": {"variance": 0.018492, "average": 0.912573, "min": 0.483002}, "location": {"width": 1035, "top": 711, "height": 116, "left": 338}, "words": "时10mg3静脉或肌肉注射给药直到血清甲氨嫂吟浓度低于102M如存"}, {"probability": {"variance": 0.025652, "average": 0.906165, "min": 0.406534}, "location": {"width": 1026, "top": 756, "height": 109, "left": 340}, "words": "胃留或梗阻,应该通过胃肠外途径给予亚叶酸。同时进行水化(3L4)并且是碳M"}, {"probability": {"variance": 0.008656, "average": 0.953818, "min": 0.537358}, "location": {"width": 960, "top": 797, "height": 93, "left": 336}, "words": "酸氢钠碱化尿液,调整碳酸氢钠的剂量使尿PH值大于等于7,应该间隔24小"}, {"probability": {"variance": 0.005197, "average": 0.962411, "min": 0.722477}, "location": {"width": 969, "top": 834, "height": 96, "left": 333}, "words": "时分析血清样本中肌酐和甲氨蝶呤的水平。如果24小时血清肌酐水平在基线上"}, {"probability": {"variance": 0.024056, "average": 0.93354, "min": 0.462206}, "location": {"width": 973, "top": 871, "height": 98, "left": 331}, "words": "增长了50%或者如果24小时甲氨蝶呤水平大于5x104M或48小时甲氨蝶呤水"}, {"probability": {"variance": 0.005775, "average": 0.97888, "min": 0.535738}, "location": {"width": 967, "top": 907, "height": 100, "left": 329}, "words": "平大于等于9×10M,那么亚叶酸钙的剂量应该增加到100mg/m2每3小时静"}, {"probability": {"variance": 0.007945, "average": 0.968368, "min": 0.499552}, "location": {"width": 973, "top": 946, "height": 98, "left": 326}, "words": "脉注射直到甲氨蝶呤水平<10M亚叶酸钙输注的速度不能超过每分钟160mL"}, {"probability": {"variance": 0.009484, "average": 0.963647, "min": 0.562361}, "location": {"width": 969, "top": 987, "height": 93, "left": 324}, "words": "160mg亚叶酸钙)。有明显第3间隙蓄积的患者具有高风险,不论他们24小时"}, {"probability": {"variance": 0.036532, "average": 0.878698, "min": 0.404673}, "location": {"width": 1060, "top": 1019, "height": 160, "left": 324}, "words": "血清甲氨蝶水平如何都要持续监测直到血清甲氨蝶呤水平小于10MOS1REU"}, {"probability": {"variance": 0.014481, "average": 0.940913, "min": 0.584117}, "location": {"width": 898, "top": 1063, "height": 91, "left": 384}, "words": "以上所提到的亚叶酸钙的刻量并不适用于大剂量甲氨蝶吟治疗在否同"}, {"probability": {"variance": 0.014379, "average": 0.955216, "min": 0.369658}, "location": {"width": 1072, "top": 1095, "height": 107, "left": 320}, "words": "的研究和发表的文献中亚叶酸钙的剂量有所不同,建议参考发表的大量甲"}, {"probability": {"variance": 0.028446, "average": 0.882545, "min": 0.564255}, "location": {"width": 228, "top": 1134, "height": 50, "left": 313}, "words": "氨蝶呤用药的文献"}, {"probability": {"variance": 0.024059, "average": 0.902933, "min": 0.488402}, "location": {"width": 978, "top": 1170, "height": 116, "left": 379}, "words": "无论足标准的血液透析或者腹膜透析都不能明显改善甲氨蛛的清除。如心"}, {"probability": {"variance": 0.010479, "average": 0.949007, "min": 0.542376}, "location": {"width": 1015, "top": 1207, "height": 105, "left": 310}, "words": "果患者完全无尿,那么通过血液透析可能会清除部分甲氨蝶呤,此没有其它它"}, {"probability": {"variance": 0.028565, "average": 0.910921, "min": 0.378534}, "location": {"width": 971, "top": 1246, "height": 100, "left": 306}, "words": "可以选择的治疗手段有道使用高通量析器进行急性间断性血液透析过甲氨"}, {"probability": {"variance": 0.025571, "average": 0.922426, "min": 0.47872}, "location": {"width": 256, "top": 1287, "height": 48, "left": 306}, "words": "蝶岭的清除是有效的"}, {"probability": {"variance": 0.000361, "average": 0.971582, "min": 0.946436}, "location": {"width": 157, "top": 1360, "height": 45, "left": 306}, "words": "【药理毒理】"}, {"probability": {"variance": 1e-06, "average": 0.998902, "min": 0.997959}, "location": {"width": 66, "top": 1399, "height": 34, "left": 294}, "words": "药理"}, {"probability": {"variance": 0.008758, "average": 0.957791, "min": 0.585939}, "location": {"width": 900, "top": 1435, "height": 98, "left": 358}, "words": "甲氨蝶岭的主要作用机理是竞争性抑制叶酸还原酶。在DNA合成和细胞复"}, {"probability": {"variance": 0.005309, "average": 0.956618, "min": 0.755126}, "location": {"width": 967, "top": 1470, "height": 102, "left": 297}, "words": "制的过程中叶酸必须被此酶还原成四氢叶酸。甲氨蝶呤抑制叶酸的还原:且平"}, {"probability": {"variance": 0.030554, "average": 0.905401, "min": 0.400974}, "location": {"width": 973, "top": 1508, "height": 102, "left": 290}, "words": "扰了组织细胞的复制:甲氨蝶呤是一种细胞周期特异性药物它生要作用于NA"}, {"probability": {"variance": 0.022388, "average": 0.926671, "min": 0.40339}, "location": {"width": 973, "top": 1547, "height": 100, "left": 285}, "words": "合成期的细胞。增殖活跃的组织如恶性肿瘤细胞、骨髓、胚胎。皮肤上皮"}, {"probability": {"variance": 0.010541, "average": 0.957249, "min": 0.473251}, "location": {"width": 731, "top": 1588, "height": 82, "left": 283}, "words": "胞、口腔和肠粘膜以及膀胱细胞通常对甲氨蝶呤作用更敏感"}, {"probability": {"variance": 0.010299, "average": 0.949522, "min": 0.57588}, "location": {"width": 976, "top": 1625, "height": 100, "left": 278}, "words": "细胞增殖比大部分正常组织中的更快,因此甲氨蝶呤可以削弱琴肿瘤的生长面"}, {"probability": {"variance": 2.4e-05, "average": 0.997485, "min": 0.979748}, "location": {"width": 425, "top": 1662, "height": 66, "left": 278}, "words": "不对正常组织产生非可逆性的损伤"}, {"probability": {"variance": 0.00073, "average": 0.967414, "min": 0.920964}, "location": {"width": 176, "top": 1636, "height": 52, "left": 1081}, "words": "母瘤组织中的"}, {"probability": {"variance": 0.000528, "average": 0.986703, "min": 0.893737}, "location": {"width": 912, "top": 1705, "height": 96, "left": 338}, "words": "银屑病时皮肤上皮细胞的增殖能力远强于正常皮肤。增殖率的差别正是使"}, {"probability": {"variance": 0.00029, "average": 0.989193, "min": 0.928031}, "location": {"width": 454, "top": 1737, "height": 68, "left": 272}, "words": "用甲氨蝶呤来控制银屑病进展的基础"}, {"probability": {"variance": 0, "average": 0.993592, "min": 0.992947}, "location": {"width": 61, "top": 1817, "height": 34, "left": 267}, "words": "毒理"}, {"probability": {"variance": 0.026914, "average": 0.921865, "min": 0.358397}, "location": {"width": 912, "top": 1856, "height": 98, "left": 326}, "words": "体外,甲氨蝶呤引起中国仓鼠A(T1)C1-3细胞的染色体变,诱导小鼠"}, {"probability": {"variance": 0.010365, "average": 0.941928, "min": 0.592775}, "location": {"width": 969, "top": 1890, "height": 102, "left": 267}, "words": "3H/0T1/2克隆8细胞的形态改变以及与小鼠淋巴瘤细胞L5178Y/tk的t基"}, {"probability": {"variance": 0.007763, "average": 0.966136, "min": 0.656835}, "location": {"width": 976, "top": 1929, "height": 102, "left": 258}, "words": "因完变率的增加有关。在体内,它引起小鼠体内多染性红细胞比率增加以及人类"}, {"probability": {"variance": 0.021927, "average": 0.903946, "min": 0.538066}, "location": {"width": 173, "top": 2016, "height": 36, "left": 653}, "words": "第15页,共15页"}], "language": 3}